This is a StreetInsider.com Premium Only Page

Kindred Biosciences (KIN) – StreetInsider.com Reports

Aug 23, 2021 01:54 PM Alliance Global Partners Downgrades Kindred Biosciences (KIN) to Neutral, Merger Imminent

Jun 17, 2021 09:02 AM Lake Street Capital Markets Downgrades Kindred Biosciences (KIN) to Hold

Jun 17, 2021 06:14 AM H.C. Wainwright Downgrades Kindred Biosciences (KIN) to Neutral

Jun 16, 2021 09:35 AM Aegis Capital Downgrades Kindred Biosciences (KIN) to Hold

Jun 16, 2021 07:55 AM Cantor Fitzgerald Downgrades Kindred Biosciences (KIN) to Neutral

Jun 16, 2021 06:34 AM Elanco (ELAN) Announces Agreement to Acquire Kindred Biosciences (KIN) for $9.25 Per Share

Jun 2, 2021 08:35 AM Kindred Biosciences (KIN) Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus

May 12, 2021 02:31 PM Kindred Biosciences (KIN) PT Raised to $15.25 at Alliance Global Partners, Following Earnings

May 12, 2021 08:37 AM Kindred Biosciences (KIN) PT Lowered to $9 at Stifel

May 11, 2021 04:37 PM Kindred Biosciences (KIN) Reports In-Line Q1 EPS, Revenues Miss

Apr 28, 2021 08:34 AM Kindred Biosciences (KIN) Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy Indication

Apr 20, 2021 04:04 PM Kindred Biosciences (KIN) Unveils Positive Results from its Long-Acting Interleukin-31 Antibody PK Study

Apr 8, 2021 06:33 AM Companies with NDRs 4/08

Mar 16, 2021 04:03 PM Kindred Biosciences (KIN) Tops Q4 EPS by 1c

Feb 9, 2021 08:45 AM Kindred Biosciences (KIN) Names Lyndon Lien, Ph.D. and Nanxi Liu to Board

Jan 26, 2021 09:49 AM Kindred Biosciences (KIN) PT Raised to $16 at Aegis Capital

Dec 21, 2020 08:33 AM Kindred Biosciences (KIN) Announces Positive Results from Pilot Field Effectiveness Study for Anti-TNFα Antibody for Canine Inflammatory Bowel Disease

Dec 11, 2020 08:07 AM Kindred Biosciences (KIN) Announces Agreement Granting Elanco (ELAN) Exclusive Global Rights for its Parvovirus Monoclonal Antibody

Oct 7, 2020 09:25 AM Pre-Open Stock Movers 10/07: (PERI) (KIN) (LEVI) Higher; (CLSK) (LNDC) (DKNG) Lower (more...)

Oct 7, 2020 08:08 AM Kindred Biosciences (KIN) Announces Expansion of Manufacturing Agreement with Vaxart (VXRT) for COVID-19 and Other Vaccine Candidates

Sep 16, 2020 08:10 AM Kindred Biosciences (KIN) Reports Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody

Jul 28, 2020 02:51 PM Kindred Biosciences (KIN) PT Lowered to $11 at Cantor Fitzgerald

Jun 26, 2020 10:52 AM Kindred Biosciences (KIN) halted on volatility after surging 12% intra-day

Jun 8, 2020 04:13 PM Kindred Biosciences (KIN) to reduce operating expenditures by prioritizing investment in its highest value, late stage programs

May 20, 2020 07:58 AM Kindred Biosciences (KIN) Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart (VXRT)

Mar 24, 2020 08:37 AM Kindred Biosciences (KIN) Reports Positive Results from Pilot Field Efficacy Study of IL-4/IL-13 SINK Molecule

Mar 17, 2020 06:54 AM Guggenheim Downgrades Kindred Biosciences (KIN) to Neutral

Mar 17, 2020 05:39 AM Kindred Biosciences (KIN) PT Lowered to $13 at Stifel

Mar 16, 2020 04:06 PM Kindred Biosciences (KIN) Misses Q4 EPS by 4c

Feb 28, 2020 01:35 PM Kindred Biosciences (KIN) Gains on Chatter

Dec 16, 2019 08:06 AM Kindred Biosciences (KIN) Unveils Positive Results from Pilot Study of Interleukin-4R Monoclonal Antibody Being Developed for Treatment of Atopic Dermatitis in Dogs

Dec 12, 2019 09:07 AM Kindred Biosciences (KIN) Announces EC Approval of Mirataz 20 mg/g Transdermal Ointment for Cats Experiencing Poor Appetite and Weight Loss

Nov 25, 2019 04:03 PM Kindred Biosciences (KIN) Receives FDA Approval of Zimeta for Control of Pyrexia in Horses

Nov 14, 2019 04:31 AM Kindred Biosciences (KIN) PT Raised to $12 at Barclays

Nov 12, 2019 04:29 PM Kindred Biosciences (KIN) Misses Q3 EPS by 2c

Oct 10, 2019 04:03 PM Kindred Biosciences (KIN) Reports Positive Opinion from CVMP in the European Union for Mirataz

Aug 5, 2019 06:50 AM Kindred Biosciences (KIN) PT Lowered to $12 at Barclays

Jul 29, 2019 07:14 AM Kindred Biosciences (KIN) Announces Positive Results from Pilot Field Effectiveness Study of its Interleukin-31 Monoclonal Antibody for Treatment of Atopic Dermatitis in Dogs

Jul 16, 2019 07:09 AM B.Riley/FBR Downgrades Kindred Biosciences (KIN) to Neutral

Jun 11, 2019 02:37 AM Barclays Starts Kindred Biosciences (KIN) at Overweight

May 23, 2019 08:54 AM UPDATE: Guggenheim Starts Kindred Biosciences (KIN) at Buy

May 22, 2019 04:20 PM Stifel Starts Kindred Biosciences (KIN) at Buy

May 9, 2019 04:53 PM Kindred Biosciences (KIN) Misses Q1 EPS by 1c

Apr 10, 2019 11:51 AM Aegis Capital Starts Kindred Biosciences (KIN) at Buy

Mar 7, 2019 03:20 AM Kindred Biosciences (KIN) PT Lowered to $18 at B.Riley/FBR

Mar 6, 2019 04:26 PM Kindred Biosciences (KIN) Misses Q4 EPS by 2c

Mar 4, 2019 09:09 AM Kindred Biosciences (KIN) PT Lowered to $19.25 at B.Riley/FBR

Jan 18, 2019 02:22 PM Kindred Biosciences (KIN) PT Lowered to $19 at Euro Pacific Capital

Jan 18, 2019 09:33 AM Kindred Biosciences (KIN) Prices 4.215M Share Common Offering at $9.50/Sh

Jan 17, 2019 04:02 PM Kindred Biosciences (KIN) Announces Proposed Common Share Offering